approval
saveSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approval
community read0 votes
Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalFeb 27, 2026 · 217d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalFeb 27, 2026 · 217d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalApr 4, 2025 · 546d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalNov 17, 2021 · 1780d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalNov 17, 2021 · 1780d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalOct 22, 2020 · 2171d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalOct 22, 2020 · 2171d ago
- approvalSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvalJun 19, 2020 · 2296d ago
comments(0)
5-min edit window · permanent after that